CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.414
EU - Europa 4.156
AS - Asia 3.058
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 190
AF - Africa 81
OC - Oceania 9
Totale 12.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.300
RU - Federazione Russa 1.760
SG - Singapore 1.191
CN - Cina 946
GB - Regno Unito 650
IT - Italia 516
BR - Brasile 317
DE - Germania 284
VN - Vietnam 252
HK - Hong Kong 220
SE - Svezia 218
FR - Francia 214
IE - Irlanda 190
FI - Finlandia 104
KR - Corea 91
IN - India 87
CA - Canada 69
BD - Bangladesh 66
JP - Giappone 57
UA - Ucraina 38
AR - Argentina 35
NL - Olanda 35
PL - Polonia 34
ES - Italia 27
MX - Messico 27
ZA - Sudafrica 26
AT - Austria 25
BE - Belgio 20
TR - Turchia 20
ID - Indonesia 18
VE - Venezuela 18
IQ - Iraq 17
NG - Nigeria 15
CL - Cile 13
CO - Colombia 13
PH - Filippine 10
UZ - Uzbekistan 10
EC - Ecuador 9
PY - Paraguay 9
TG - Togo 9
IR - Iran 8
PK - Pakistan 8
AZ - Azerbaigian 7
MA - Marocco 7
AU - Australia 6
BJ - Benin 5
CZ - Repubblica Ceca 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
NP - Nepal 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
DK - Danimarca 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
Totale 12.125
Salva come PNG Salva come JPEG
Città #
Singapore 648
Moscow 630
Southend 555
Ashburn 540
Chandler 478
San Jose 418
Dallas 412
Hong Kong 216
Dublin 189
Council Bluffs 165
Beijing 162
Jacksonville 136
Redmond 134
Verona 134
New York 131
The Dalles 115
Los Angeles 99
Ann Arbor 94
Ho Chi Minh City 83
Bologna 72
Lawrence 70
Princeton 70
Wilmington 68
Woodbridge 66
Helsinki 59
Hanoi 56
Shenyang 55
Munich 53
Tokyo 53
Jinan 50
Nanjing 45
Santa Clara 40
Buffalo 38
Houston 38
Milan 38
Redondo Beach 37
São Paulo 36
Denver 35
Tianjin 35
Hebei 34
Sindelfingen 30
Orem 28
Montreal 27
Zhengzhou 27
Warsaw 26
Haikou 25
Hangzhou 25
Ningbo 25
Changsha 23
Chicago 23
Columbus 23
Brooklyn 22
Guangzhou 22
London 22
Phoenix 21
Taiyuan 21
Seattle 20
Brussels 19
Hyderabad 19
Washington 19
Vienna 18
Frankfurt am Main 17
Falkenstein 16
Johannesburg 16
Poplar 16
Abuja 15
Nanchang 15
San Francisco 15
Taizhou 15
Turku 15
Atlanta 14
Boston 14
Norwalk 14
Redwood City 14
Jiaxing 13
Manchester 13
Rome 12
Venice 12
Amsterdam 11
Chennai 11
Dong Ket 11
Fuzhou 11
Rio de Janeiro 11
Toronto 11
Fairfield 10
Mexico City 10
Mumbai 10
Tashkent 10
Da Nang 9
Lomé 9
Seoul 9
Charlotte 8
Jakarta 8
Naples 8
Paris 8
Baku 7
Buenos Aires 7
Haiphong 7
Kent 7
Palermo 7
Totale 7.318
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 274
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 247
Anti-CCP antibodies and bone 246
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 230
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 216
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 216
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 208
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 205
Bone involvement and osteoporosis in mastocytosis. 204
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 204
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 200
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 188
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 185
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 184
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 181
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 178
Osteoporosis treatment: why ibandronic acid? 177
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 175
Bone Disease in Mastocytosis 173
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 172
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 171
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 170
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 167
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 166
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 166
Association between environmental air pollution and rheumatoid arthritis flares 166
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 163
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 163
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 160
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 158
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 158
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 153
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 152
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 151
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 149
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 148
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 146
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 145
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 143
Rheumatoid arthritis, γδ T cells and bisphosphonates 143
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 142
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 140
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 140
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 139
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 138
Changes in bone turnover markers and bone modulators during abatacept treatment 137
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 137
Osteoporosis in Rheumatic Diseases 134
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 134
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 133
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 132
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 132
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 131
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 128
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 127
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 122
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 122
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 121
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 120
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 120
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 117
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 116
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 115
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 113
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 113
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 112
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 112
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 107
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 103
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 102
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 98
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 97
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 97
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 93
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 92
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 91
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 88
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 84
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 83
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 77
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 75
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 74
Prevalence and determinants of vertebral fractures in a SLE cohort 70
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 69
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 45
Totale 12.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.944
article - articoli 44.465
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 479
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022380 0 0 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/20251.710 82 103 77 285 90 50 76 68 265 152 140 322
2025/20265.736 368 286 376 973 1.530 390 535 306 403 262 155 152
2026/2027200 60 139 1 0 0 0 0 0 0 0 0 0
Totale 12.330